The University of Chicago Header Logo

Connection

Clarissa Parker to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Clarissa Parker has written about Drug Resistance, Neoplasm.
Clarissa Parker
Connection Strength
0.136
Drug Resistance, Neoplasm
  1. Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer. Anticancer Drugs. 2006 Jul; 17(6):697-704.
    View in: PubMed
    Score: 0.101
  2. Personalized treatment of lung cancer. Semin Oncol. 2011 Apr; 38(2):274-83.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.